Narval

At Narval we design synthetic Antibody Mimetic Proteins (AMP) to replace monoclonal antibodies in novel, first-in-class, and unconventional antibody drugs. With marine biotechnology and AI we develop antibody drugs that, until now, have been impossible to develop.